Journal of Medicinal Chemistry p. 1556 - 1564 (2016)
Update date:2022-08-03
Topics:
Kuntz, Kevin W.
Campbell, John E.
Keilhack, Heike
Pollock, Roy M.
Knutson, Sarah K.
Porter-Scott, Margaret
Richon, Victoria M.
Sneeringer, Chris J.
Wigle, Tim J.
Allain, Christina J.
Majer, Christina R.
Moyer, Mikel P.
Copeland, Robert A.
Chesworth, Richard
Posttranslational methylation of histones plays a critical role in gene regulation. Misregulation of histone methylation can lead to oncogenic transformation. Enhancer of Zeste homologue 2 (EZH2) methylates histone 3 at lysine 27 (H3K27) and abnormal methylation of this site is found in many cancers. Tazemetostat, an EHZ2 inhibitor in clinical development, has shown activity in both preclinical models of cancer as well as in patients with lymphoma or INI1-deficient solid tumors. Herein we report the structure-activity relationships from identification of an initial hit in a high-throughput screen through selection of tazemetostat for clinical development. The importance of several methyl groups to the potency of the inhibitors is highlighted as well as the importance of balancing pharmacokinetic properties with potency.
View MoreSHANGHAI T&W PHARMACEUTICAL CO., LTD.
website:http://www.trustwe.com
Contact:+86-21-61551611
Address:601, No. 1, 2277 Nong, Zu Chongzhi Road, Zhangjiang Hightech. Park, Pudong
Contact:+86+21-58956006 15800617331
Address:402 Room, 150# Cailun Road, Zhangjiang high tech park, Shanghai
Tianjin Anda North Industrial & Business Co.Ltd.
Contact:86-22-24999306
Address:No.11 Erwei Road,Dongli Development Area,Tianjin,China
website:http://www.truewingroup.com
Contact:86-311-66699812
Address:NO.600 ZHONGSHAN EAST ROAD SHIJIAZHUANG
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Doi:10.1055/s-1993-25809
(1993)Doi:10.1016/j.ssc.2005.08.021
(2005)Doi:10.14233/ajchem.2015.17144
(2015)Doi:10.1016/S0957-4166(00)80191-3
(1992)Doi:10.1002/anie.202010682
(2020)Doi:10.1080/10610278.2012.720021
(2012)